Skip to main content
. 2021 Aug 15;11(8):3893–3906.

Figure 7.

Figure 7

MRI images of two cases with FGFR3-TACC3 fusions at different time points after anlotinib use. A: A 65-year-old women diagnosed as glioblastoma multiforme in the right splenium of corpus callosum; B: A 46-year-old women with glioma in the left thalamus and parietal lobe.